Meet the Team

Along with David, Saye provides the team’s strategic leadership. He gives a clinical lead to the development of website content and represents the website team at national and international meetings. He is particularly interested in harnessing the technology of the websites to continuously improve patient care. Saye was awarded an MBE in the 2024 New Year's Honours List.

Catia is the responsible lead for predicting drug-drug interactions where no clinical data is yet available using a mechanistic approach. She creates drug-drug interactions guidance documents for various therapeutic classes and other prescribing documents. In addition, she contributes to the content development of the website and represents the website team at international conferences and meetings, as well as in the EACS guidelines panel.

Along with Saye, David provides the team’s strategic leadership. He gives a scientific lead to the development of website content, represents the website team at international conferences and events and helps shape the future development and direction of the resources we produce.

Lauren is one of the senior investigators in the AGILE trial which evaluates potential COVID-19 treatments in an early phase clinical trial platform and joined the website team in 2022. Her research interest involves utilising existing health record data to understand how multiple long-term conditions, and their associated prescriptions, evolve over time and how these relationships between drugs and diseases lead to harm. She is very interested in predicting risk and examining patient journeys to identify at what point the harm of a medicine outweighs the potential for benefit.

Sara is responsible for the general administration of the website and manages and updates its content, ensuring quality and consistency are maintained.

Daryl completed their PhD in Clinical Biochemistry in 2013 and, after post-doctoral research posts in physiology and pharmacology, joined the website team in August 2018.  Daryl's main role is the management of the hepatitis website, but also assists with the updating of the HIV interaction database.

Jasmine obtained a BSc (Hons) degree in Pharmacology from the University of Liverpool in 2016 and, after completing a Master degree by research, she joined the website team in August 2017 working mainly on the cancer drug interactions website. In March 2020, Jasmine took up the post of Development Manager for all the websites (HIV, HEP, COVID and Cancer) and is responsible for developing partnerships and projects which support our mission and ethos.

Justin is responsible for finance and analysing the websites’ performance. He also provides general administrative support to all aspects of the team’s activity.

Fiona supports the interaction team when assessing those drug-drug interactions where clinical data is as yet unavailable.

Alison is an advanced BBV pharmacist and a qualified independent prescriber. Alison uses her clinical knowledge to contribute to the production of drug-drug interaction content for the website.

Daniel obtained a BSc (Hons) degree in Pharmacology from the University of Liverpool in 2018 and a Masters degree by research in 2019. After spending time working in a hospital pharmacy and a virology laboratory, Daniel joined the website team in 2021 working first on the cancer drug interactions website before moving to the COVID-19 website.